Cargando…

Irritable Bowel Syndrome and Risk of Parkinson’s Disease in Finland: A Nationwide Registry-Based Cohort Study

BACKGROUND: The gastrointestinal tract is considered as a potential origin of Parkinson’s disease (PD) pathology. Besides constipation, appendectomy and inflammatory bowel disease have also been associated with a higher PD-risk, but findings have been inconsistent. To date, there is only one previou...

Descripción completa

Detalles Bibliográficos
Autores principales: Mertsalmi, Tuomas H., But, Anna, Pekkonen, Eero, Scheperjans, Filip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150653/
https://www.ncbi.nlm.nih.gov/pubmed/33646176
http://dx.doi.org/10.3233/JPD-202330
_version_ 1783698199131717632
author Mertsalmi, Tuomas H.
But, Anna
Pekkonen, Eero
Scheperjans, Filip
author_facet Mertsalmi, Tuomas H.
But, Anna
Pekkonen, Eero
Scheperjans, Filip
author_sort Mertsalmi, Tuomas H.
collection PubMed
description BACKGROUND: The gastrointestinal tract is considered as a potential origin of Parkinson’s disease (PD) pathology. Besides constipation, appendectomy and inflammatory bowel disease have also been associated with a higher PD-risk, but findings have been inconsistent. To date, there is only one previous study suggesting that irritable bowel syndrome (IBS) is associated with an increased risk of PD. OBJECTIVE: To evaluate whether IBS is associated with a higher risk of PD. METHODS: In this retrospective registry-based cohort study, we identified 28,150 patients that were diagnosed with IBS (IBS+) during the years 1998–2014, using data from the Finnish Care Register for Health Care. In addition, 98,789 IBS-free reference subjects (IBS-) of same age and gender and living in the same municipality were included. The study subjects were followed until the end of the year 2014 to analyze the incidence of PD. The association between IBS and PD was assessed by a Cox proportional hazards model. RESULTS: Diagnosis of IBS was associated with a higher hazard of PD with an adjusted hazard ratio (aHR) of 1.70 (95% CI 1.27–2.26). However, the ratio of hazard rates for PD between IBS+ and IBS- subjects was not constant over time. The Cox model with time-varying coefficient for IBS status showed that the hazard of PD was significantly higher in IBS patients only during the first two years of follow-up (aHR 2.96, 95% CI 1.78–4.92). CONCLUSION: Our findings indicate that the association between IBS and PD is likely explained by reverse causation and detection bias. It remains open whether IBS is an actual risk factor or a prodromal symptom of PD.
format Online
Article
Text
id pubmed-8150653
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-81506532021-06-09 Irritable Bowel Syndrome and Risk of Parkinson’s Disease in Finland: A Nationwide Registry-Based Cohort Study Mertsalmi, Tuomas H. But, Anna Pekkonen, Eero Scheperjans, Filip J Parkinsons Dis Research Report BACKGROUND: The gastrointestinal tract is considered as a potential origin of Parkinson’s disease (PD) pathology. Besides constipation, appendectomy and inflammatory bowel disease have also been associated with a higher PD-risk, but findings have been inconsistent. To date, there is only one previous study suggesting that irritable bowel syndrome (IBS) is associated with an increased risk of PD. OBJECTIVE: To evaluate whether IBS is associated with a higher risk of PD. METHODS: In this retrospective registry-based cohort study, we identified 28,150 patients that were diagnosed with IBS (IBS+) during the years 1998–2014, using data from the Finnish Care Register for Health Care. In addition, 98,789 IBS-free reference subjects (IBS-) of same age and gender and living in the same municipality were included. The study subjects were followed until the end of the year 2014 to analyze the incidence of PD. The association between IBS and PD was assessed by a Cox proportional hazards model. RESULTS: Diagnosis of IBS was associated with a higher hazard of PD with an adjusted hazard ratio (aHR) of 1.70 (95% CI 1.27–2.26). However, the ratio of hazard rates for PD between IBS+ and IBS- subjects was not constant over time. The Cox model with time-varying coefficient for IBS status showed that the hazard of PD was significantly higher in IBS patients only during the first two years of follow-up (aHR 2.96, 95% CI 1.78–4.92). CONCLUSION: Our findings indicate that the association between IBS and PD is likely explained by reverse causation and detection bias. It remains open whether IBS is an actual risk factor or a prodromal symptom of PD. IOS Press 2021-04-13 /pmc/articles/PMC8150653/ /pubmed/33646176 http://dx.doi.org/10.3233/JPD-202330 Text en © 2021 – The authors. Published by IOS Press https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) License (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Report
Mertsalmi, Tuomas H.
But, Anna
Pekkonen, Eero
Scheperjans, Filip
Irritable Bowel Syndrome and Risk of Parkinson’s Disease in Finland: A Nationwide Registry-Based Cohort Study
title Irritable Bowel Syndrome and Risk of Parkinson’s Disease in Finland: A Nationwide Registry-Based Cohort Study
title_full Irritable Bowel Syndrome and Risk of Parkinson’s Disease in Finland: A Nationwide Registry-Based Cohort Study
title_fullStr Irritable Bowel Syndrome and Risk of Parkinson’s Disease in Finland: A Nationwide Registry-Based Cohort Study
title_full_unstemmed Irritable Bowel Syndrome and Risk of Parkinson’s Disease in Finland: A Nationwide Registry-Based Cohort Study
title_short Irritable Bowel Syndrome and Risk of Parkinson’s Disease in Finland: A Nationwide Registry-Based Cohort Study
title_sort irritable bowel syndrome and risk of parkinson’s disease in finland: a nationwide registry-based cohort study
topic Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150653/
https://www.ncbi.nlm.nih.gov/pubmed/33646176
http://dx.doi.org/10.3233/JPD-202330
work_keys_str_mv AT mertsalmituomash irritablebowelsyndromeandriskofparkinsonsdiseaseinfinlandanationwideregistrybasedcohortstudy
AT butanna irritablebowelsyndromeandriskofparkinsonsdiseaseinfinlandanationwideregistrybasedcohortstudy
AT pekkoneneero irritablebowelsyndromeandriskofparkinsonsdiseaseinfinlandanationwideregistrybasedcohortstudy
AT scheperjansfilip irritablebowelsyndromeandriskofparkinsonsdiseaseinfinlandanationwideregistrybasedcohortstudy